Position in SANA
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$2,944,687
+$514,687 QoQ
Shares Held
843,750
0.0% QoQ
Ownership
0.282%
of shares outstanding
% of Portfolio
1.59%
of 13F equity value
Holder Rank
#26
of 211 holders
Holding Since
Mar 2021
22 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in SANA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Omega Fund Management, LLC holds $139,057,890 across 8 Biotechnology names. SANA ranks #5 (2.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | BCAX |
Bicara Therapeutics Inc.
|
1,822,150 | $54,099,633 | |
| 2 | NUVB |
Nuvation Bio Inc.
|
8,081,089 | $45,900,585 | |
| 3 | BBOT |
BridgeBio Oncology Therapeutics, Inc.
|
3,289,661 | $25,067,216 | |
| 4 | ALMS |
Alumis Inc.
|
241,255 | $6,788,915 | |
| 5 | SANA |
Sana Biotechnology, Inc.
This page
|
843,750 | $2,944,687 | |
| 6 | IMA |
ImageneBio, Inc.
|
455,361 | $2,686,629 | |
| 7 | ENGN |
enGene Therapeutics Inc.
|
876,357 | $1,516,097 | |
| 8 | ODTX |
Odyssey Therapeutics, Inc.
|
2,893 | $54,128 |
All Filings in SANA
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,944,687 | 843,750 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $2,430,000 | 843,750 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $3,434,062 | 843,750 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $2,995,312 | 843,750 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $2,303,437 | 843,750 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $1,417,500 | 843,750 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $1,375,312 | 843,750 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $3,510,000 | 843,750 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $4,606,875 | 843,750 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $8,437,500 | 843,750 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $3,442,500 | 843,750 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $3,265,312 | 843,750 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $5,028,750 | 843,750 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $2,759,062 | 843,750 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $3,332,812 | 843,750 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $5,062,500 | 843,750 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $5,425,312 | 843,750 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $6,969,375 | 843,750 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $13,061,250 | 843,750 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $19,001,250 | 843,750 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $16,588,125 | 843,750 | Shares | Sole | 2021-11-15 | |
| 2021-03-31 | $28,240,312 | 843,750 | Shares | Sole | 2021-11-15 | |
| No filing history on record for this holder in this stock. | ||||||